Cargando…

Biomarkers and phenotypic expression in Alzheimer’s disease: exploring the contribution of frailty in the Alzheimer’s Disease Neuroimaging Initiative

The present study aimed at investigating if the main biomarkers of Alzheimer’s disease (AD) neuropathology and their association with cognitive disturbances and dementia are modified by the individual’s frailty status. We performed a cross-sectional analysis of data from participants with normal cog...

Descripción completa

Detalles Bibliográficos
Autores principales:	Canevelli, Marco, Arisi, Ivan, Bacigalupo, Ilaria, Arighi, Andrea, Galimberti, Daniela, Vanacore, Nicola, D’Onofrio, Mara, Cesari, Matteo, Bruno, Giuseppe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8110661/ https://www.ncbi.nlm.nih.gov/pubmed/33210215 http://dx.doi.org/10.1007/s11357-020-00293-y

Ejemplares similares

Methodological Issues in the Clinical Validation of Biomarkers for Alzheimer’s Disease: The Paradigmatic Example of CSF
por: Canevelli, Marco, et al.
Publicado: (2019)

Use of Biomarkers in Ongoing Research Protocols on Alzheimer’s Disease
por: Canevelli, Marco, et al.
Publicado: (2020)

Anticancer drugs repurposed for Alzheimer’s disease: a systematic review
por: Ancidoni, Antonio, et al.
Publicado: (2021)

An ontology-based approach for modelling and querying Alzheimer’s disease data
por: Taglino, Francesco, et al.
Publicado: (2023)

External Validity of Randomized Controlled Trials on Alzheimer’s Disease: The Biases of Frailty and Biological Aging
por: Canevelli, Marco, et al.
Publicado: (2017)

Alzheimer's Disease and Cognitive Frailty: Novel Therapeutic Technologies
por: D'Onofrio, Grazia, et al.
Publicado: (2016)

An Estimate of Attributable Cases of Alzheimer Disease and Vascular Dementia due to Modifiable Risk Factors: The Impact of Primary Prevention in Europe and in Italy
por: Mayer, Flavia, et al.
Publicado: (2018)

Safety and Efficacy of Monoclonal Antibodies for Alzheimer’s Disease: A Systematic Review and Meta-Analysis of Published and Unpublished Clinical Trials
por: Lacorte, Eleonora, et al.
Publicado: (2022)

Spontaneous Reversion of Clinical Conditions Measuring the Risk Profile of the Individual: From Frailty to Mild Cognitive Impairment
por: Canevelli, Marco, et al.
Publicado: (2017)

Time dynamics of protein complexes in the AD11 transgenic mouse model for Alzheimer’s disease like pathology
por: Arisi, Ivan, et al.
Publicado: (2015)

Q & A: The Alzheimer's disease neuroimaging initiative
por: Aisen, Paul S
Publicado: (2011)

Targeting the Cation-Chloride Co-Transporter NKCC1 to Re-Establish GABAergic Inhibition and an Appropriate Excitatory/Inhibitory Balance in Selective Neuronal Circuits: A Novel Approach for the Treatment of Alzheimer’s Disease
por: Capsoni, Simona, et al.
Publicado: (2022)

Clinical and cognitive characteristics of preclinical Alzheimer's disease in the Japanese Alzheimer's Disease Neuroimaging Initiative cohort
por: Ihara, Ryoko, et al.
Publicado: (2018)

Clusters of male and female Alzheimer’s disease patients in the Alzheimer’s Disease Neuroimaging Initiative (ADNI) database
por: Gamberger, Dragan, et al.
Publicado: (2016)

Using the Alzheimer's Disease Neuroimaging Initiative to improve early detection, diagnosis, and treatment of Alzheimer's disease
por: Veitch, Dallas P., et al.
Publicado: (2021)

The Role of Glymphatic System in Alzheimer’s and Parkinson’s Disease Pathogenesis
por: Buccellato, Francesca R., et al.
Publicado: (2022)

Editorial: Dementia, Frailty and Aging
por: Lim, Wee-Shiong, et al.
Publicado: (2018)

The prevalence and biomarkers’ characteristic of rapidly progressive Alzheimer's disease from the Alzheimer's Disease Neuroimaging Initiative database
por: Ba, Maowen, et al.
Publicado: (2017)

Neuroimaging Biomarkers for Alzheimer’s Disease
por: Márquez, Freddie, et al.
Publicado: (2019)

COVID-19 and dementia: Recommendations from the Italian dementia national plan working group
por: Canevelli, Marco, et al.
Publicado: (2021)

Potential fluid biomarkers for pathological brain changes in Alzheimer's disease: Implication for the screening of cognitive frailty
por: Ruan, Qingwei, et al.
Publicado: (2016)

Vascular and Alzheimer's disease markers independently predict brain atrophy rate in Alzheimer's Disease Neuroimaging Initiative controls
por: Barnes, Josephine, et al.
Publicado: (2013)

Frailty as a Predictor of Cognitive Disorders: A Systematic Review and Meta-Analysis
por: Borges, Marcus Kiiti, et al.
Publicado: (2019)

Potential neuroimaging biomarkers of pathologic brain changes in Mild Cognitive Impairment and Alzheimer’s disease: a systematic review
por: Ruan, Qingwei, et al.
Publicado: (2016)

Nutrition, frailty, and Alzheimer's disease
por: Panza, Francesco, et al.
Publicado: (2014)

Neuroimaging Measures as Endophenotypes in Alzheimer's Disease
por: Braskie, Meredith N., et al.
Publicado: (2011)

Neuroimaging of Mouse Models of Alzheimer’s Disease
por: Jullienne, Amandine, et al.
Publicado: (2022)

Multivariate Protein Signatures of Pre-Clinical Alzheimer's Disease in the Alzheimer's Disease Neuroimaging Initiative (ADNI) Plasma Proteome Dataset
por: Johnstone, Daniel, et al.
Publicado: (2012)

Effects of traumatic brain injury and posttraumatic stress disorder on Alzheimer’s disease in veterans, using the Alzheimer’s Disease Neuroimaging Initiative
por: Weiner, Michael W., et al.
Publicado: (2014)

Presumed small vessel disease, imaging and cognition markers in the Alzheimer’s Disease Neuroimaging Initiative
por: Fiford, Cassidy M, et al.
Publicado: (2021)

Mapping longitudinal scientific progress, collaboration and impact of the Alzheimer’s disease neuroimaging initiative
por: Yao, Xiaohui, et al.
Publicado: (2017)

Generation and quality control of lipidomics data for the alzheimer’s disease neuroimaging initiative cohort
por: Barupal, Dinesh Kumar, et al.
Publicado: (2018)

The Worldwide Alzheimer's Disease Neuroimaging Initiative: ADNI‐3 updates and global perspectives
por: Weber, Christopher J., et al.
Publicado: (2021)

Identification of prognostic factors to predict cognitive decline of patients with early Alzheimer's disease in the Japanese Alzheimer's Disease Neuroimaging Initiative study
por: Yagi, Takuya, et al.
Publicado: (2019)

Association between polygenic risk score of Alzheimer’s disease and plasma phosphorylated tau in individuals from the Alzheimer’s Disease Neuroimaging Initiative
por: Zettergren, Anna, et al.
Publicado: (2021)

Oral frailty and neurodegeneration in Alzheimer’s disease
por: Dibello, Vittorio, et al.
Publicado: (2021)

Applications of Neuroimaging to Disease-Modification Trials in Alzheimer’s Disease
por: Fleisher, Adam S., et al.
Publicado: (2009)

Sensitivity and specificity of neuroimaging for the diagnosis of Alzheimer's disease
por: Wollman, Daniel E., et al.
Publicado: (2003)

Deep Learning with Neuroimaging and Genomics in Alzheimer’s Disease
por: Lin, Eugene, et al.
Publicado: (2021)

Correlation of plasma and neuroimaging biomarkers in Alzheimer's disease
por: Brickman, Adam M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_55f8ou1ooqs95rjlf712r3ufcj